QuarterlyIQ Insights · CTRA
Price
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Price
Daily closes. Earnings/event dots inline.
What it's worth (estimated)
A consensus fair price across 0 valuation methods, at three horizons. Current price $32.56. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Long-thesis check; widest uncertainty.
By method
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Conf. |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $52.41 | 9.9 | 5.28 | TTM | 50 |
| Peer P/FCF | 12M | $51.22 | 19.7 | 2.59 | TTM | 50 |
| Peer P/E | 12M | $29.99 | 20.5 | 1.46 | TTM | 50 |
| Peer P/S | 12M | $16.60 | 2.3 | 7.12 | TTM | 50 |
| Own P/E history | 12M | $17.99 | 12.3 | 1.46 | TTM | 50 |
| Peer P/FCF | 3Y | $27.51 | 19.7 | 1.39 | Hist. CAGR(prov.) | 60 |
| Peer P/S | 3Y | $12.78 | 2.3 | 5.48 | Hist. CAGR(prov.) | 60 |
| Peer P/FCF | 5Y | $18.18 | 19.7 | 0.92 | Hist. CAGR(prov.) | 60 |
| Peer P/S | 5Y | $10.74 | 2.3 | 4.61 | Hist. CAGR(prov.) | 60 |
Composite score history
Daily snapshots of the composite. Zero is the dotted line. Above it leans positive.
P/E history
Monthly trailing P/E with quartile reference lines.
Composite score history currently shows a rolling 60-day window. We're extending it back through full coverage and adding a “consensus-then vs. actual-now” overlay (what our valuation estimate said on a past date versus where the price actually landed).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.